Privia Health Group (NASDAQ:PRVA) CFO Sells $192,809.85 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 7,697 shares of the company’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $25.05, for a total value of $192,809.85. Following the completion of the sale, the chief financial officer directly owned 172,909 shares in the company, valued at approximately $4,331,370.45. The trade was a 4.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

David Mountcastle also recently made the following trade(s):

• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The shares were sold at an average price of $25.00, for a total value of $134,025.00.
• On Friday, December 12th, David Mountcastle sold 23,887 shares of Privia Health Group stock. The shares were sold at an average price of $25.03, for a total transaction of $597,891.61.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $24.30 on Thursday. The firm’s 50-day moving average price is $23.07 and its 200-day moving average price is $23.54. The company has a market capitalization of $3.01 billion, a PE ratio of 142.94, a P/E/G ratio of 1.59 and a beta of 0.82. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, February 26th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.04 by $0.21. The business had revenue of $541.17 million for the quarter, compared to analyst estimates of $516.61 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. Privia Health Group’s quarterly revenue was up 17.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.21 earnings per share. Equities analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Barclays lifted their price objective on Privia Health Group from $22.00 to $23.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. BMO Capital Markets initiated coverage on Privia Health Group in a research report on Thursday, November 13th. They issued an “outperform” rating and a $30.00 price target for the company. Jefferies Financial Group reiterated a “buy” rating and issued a $32.00 price target on shares of Privia Health Group in a research note on Thursday, February 26th. Wolfe Research set a $31.00 price objective on shares of Privia Health Group in a research note on Tuesday, January 6th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Privia Health Group from $32.00 to $33.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $31.00.

Hedge Funds Weigh In On Privia Health Group

Hedge funds have recently bought and sold shares of the business. Great Lakes Advisors LLC purchased a new position in shares of Privia Health Group during the third quarter valued at approximately $4,487,000. Advantage Alpha Capital Partners LP bought a new stake in Privia Health Group in the 2nd quarter worth approximately $3,941,000. Hsbc Holdings PLC raised its stake in Privia Health Group by 69.2% during the 2nd quarter. Hsbc Holdings PLC now owns 113,718 shares of the company’s stock valued at $2,549,000 after buying an additional 46,526 shares during the last quarter. Edgestream Partners L.P. purchased a new stake in Privia Health Group during the 2nd quarter valued at $2,209,000. Finally, Bailard Inc. bought a new position in shares of Privia Health Group during the 2nd quarter valued at $531,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.